The term “risk-based monitoring” (or RBM) has been widely used throughout the pharmaceutical industry, but what it really means and how it is implemented is the source of much...
Read Article
Get the straight story on RBM in our new white paper Over the past few years, there has been much debate regarding the definition of risk-based monitoring. To put it in context, clinical monitoring...
Read Article
RBM (Risk-Based Monitoring) has been gaining traction since 2010 and has been called “the future of clinical trials.” This infographic explores what it means to truly perform RBM and how this...
Read Article
A look back at the role of technology in clinical trials shows a succession of systems, each adopted to improve the speed, efficiency, and/or quality of the clinical development process while also...
Read ArticlePharmaceutical Outsourcing – Six Considerations When Implementing Machine Learning Algorithms in Clinical Research
by Dr. Basheer Hawwash, Principal Data Scientis
Applied Clinical Trials – How to Manage Machine Learning Algorithms in Clinical Trials
by Dr. Basheer Hawwash, Principal Data Scientist
CIOReview – Remarque Systems: Consolidating Patient Data for Better Clinical Trials
The first QMS that allows you to implement risk-based monitoring (RBM) methodology at scale. In this video, Mike Arlotto, founder of Remarque Systems, discusses how the Remarque Quality Management...
Read Article
Flexible access to clean, high-quality data and effective risk management are more vital than ever to the success of clinical drug trials. The Remarque Quality Management System is the first that...
Read Article
Flexible access to clean, high-quality data and effective risk management are more vital than ever to the success of clinical drug trials. The Remarque Quality Management System is the first that...
Read ArticleThe term “risk-based monitoring” (or RBM) has been widely used throughout the pharmaceutical industry, but what it really means and how it is implemented is the source of much...
Read Article